Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study-Reference-Cited by-同舟云学术

Comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study

Published:2004-01 Issue:1 Volume:137 Page:210-211
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Noecker Robert S.,Dirks Monte S.,Choplin Neil

Publisher

Elsevier BV

Subject

Ophthalmology

Reference7 articles.

1. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma;Noecker;Am J Ophthalmol,2003

2. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure;DuBiner;Surv Ophthalmol,2001

3. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension;Gandolfi;Adv Ther,2001

4. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension;Netland;Am J Ophthalmol,2001

5. Efficacy and safety of latanoprost eye drops for glaucoma treatment;Suzuki;Jpn J Ophthalmol,2000

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgenetic alopecia: combing the hair follicle signaling pathways for new therapeutic targets and more effective treatment options;Expert Opinion on Therapeutic Targets;2019-09-01

2. Tafluprost for glaucoma;Expert Opinion on Pharmacotherapy;2011-09-15

3. Current and emerging medical therapies in the treatment of glaucoma;Expert Opinion on Emerging Drugs;2011-04-07

4. Characterization of anin vivomodel for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost;British Journal of Dermatology;2010-03-12

5. Bimatoprost – a review;Expert Opinion on Pharmacotherapy;2009-10-30